{"edit_history_tweet_ids": ["1549050124239716353"], "created_at": "2022-07-18T15:15:04.000Z", "author_id": "3114448031", "id": "1549050124239716353", "text": "Stock: $ABBV - AbbVie Inc.\n*** NEWS ***\n2022-07-18 | NYSE:ABBV | Press Release | AbbVie Inc. - Stockhouse\nhttps://t.co/JKGRjCqgPS\nTry now the Best Pivot Point Calculator!! https://t.co/CFmq8XKUtR\n#tradingview\n#stocks\n#stockstowatch https://t.co/B2tyVZc1nn"}
{"id": "1548910896264937472", "text": "$ABBV AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine\nhttps://t.co/90f17ueLHf", "created_at": "2022-07-18T06:01:49.000Z", "author_id": "1355194932445786112", "edit_history_tweet_ids": ["1548910896264937472"]}
{"id": "1549176111271116801", "text": "Trending: Pharmaceutical\n\n$JNJ -2.10 %\n$ETON 5.38 %\n$NVS -1.82 %\n$SIGA -5.88 %\n$MRK -2.69 %\n$ABBV -2.94 %\n$ACB 5.47 %\n$PFE -1.84 %\n$ADIL 13.50 %\n$LLY -2.77 %\n\nhttps://t.co/WV3qS0l6fi", "edit_history_tweet_ids": ["1549176111271116801"], "author_id": "1448619461892771843", "created_at": "2022-07-18T23:35:41.000Z"}
